No Data
NovaBay Pharmaceuticals (NBY) Upgraded to Buy: Here's Why
NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
NovaBay Pharmaceuticals To Reconvene Special Meeting Of Stockholders To December 18, 2024; Initial Meeting Adjourned Due To Insufficient Votes To Reach The 50% Threshold Of Outstanding Common Shares Voting In Favor Of Proposal One And Two
Express News | NovaBay Pharmaceuticals: Iss Supports Co's Proposals to Authorize Sale of Its Avenova Brand
Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of Its Avenova Brand
NovaBay Pharmaceuticals Reports Q3 2024 Financials Amid Strategic Changes
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
